We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,599 results
  1. Triptolide attenuates irritable bowel syndrome via inhibiting ODC1

    Background

    Irritable bowel syndrome (IBS) is a chronic disorder of the gut-brain axis with significant morbidity. Triptolide, an active compound...

    Ning Zhu, Liuyan Zhu, ... Bingwu Huang in BMC Gastroenterology
    Article Open access 12 June 2023
  2. Triptolide regulates the balance of Tfr/Tfh in lupus mice

    Introduction/objectives

    Systemic lupus erythematosus (SLE) is a classic prototype of the multisystem autoimmune disease and follows a relapsing and...

    **a Zhao, Wei Ji, ... Feng Guo in Advances in Rheumatology
    Article Open access 05 July 2023
  3. Let-7b-5p promotes triptolide-induced growth-inhibiting effects in glioma by targeting IGF1R

    Glioma is one of the most common malignancies of the central nervous system. The therapeutic effect has not been satisfactory despite advances in...

    **hong Liu, Peiyuan Zhao, ... Yulong Chen in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 16 February 2024
  4. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer

    Paclitaxel resistance is associated with a poor prognosis in non-small cell lung cancer (NSCLC) patients, and currently, there is no promising drug...

    Ling-bing Li, Ling-xiao Yang, ... **ao-gang Zhao in Acta Pharmacologica Sinica
    Article Open access 16 January 2024
  5. Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease

    Alzheimer disease (AD) is a common neurodegenerative disease with pathological features of accumulated amyloid plaques, neurofibrillary tangles, and...

    Zuoting He, Benson O.A. Botchway, ... Xuehong Liu in Metabolic Brain Disease
    Article 25 August 2023
  6. Antitumor mechanisms and future clinical applications of the natural product triptolide

    Triptolide (TPL) is a compound sourced from Tripterygium wilfordii Hook. F., a traditional Chinese medicinal herb recognized for its impressive...

    Shiwei Bao, Mei Yi, ... Pan Chen in Cancer Cell International
    Article Open access 27 April 2024
  7. Glycosylated triptolide affords a potent in vivo therapeutic activity to hepatocellular carcinoma in mouse model

    While studies have demonstrated the therapeutic potential of triptolide for different cancers including hepatocellular carcinoma (HCC), its...

    Jian Xue, Feng Pan, ... Frank Shujie Hou in Medicinal Chemistry Research
    Article 26 December 2022
  8. Triptolide induces PANoptosis in macrophages and causes organ injury in mice

    Macrophages represent the first lines of innate defense against pathogenic infections and are poised to undergo multiple forms of regulated cell...

    Hong-Rui Zhang, Ya-** Li, ... **an-Hui He in Apoptosis
    Article 13 September 2023
  9. Triptolide mitigates the inhibition of osteogenesis induced by TNF-α in human periodontal ligament stem cells via the p-IκBα/NF-κB signaling pathway: an in-vitro study

    Background

    Triptolide is a widely utilized natural anti-inflammatory drug in clinical practice. Aim of this study was to evaluate effects of...

    Hao Chen, Lina Zhang, ... Jun Zhang in BMC Complementary Medicine and Therapies
    Article Open access 06 March 2024
  10. Tandemly duplicated CYP82Ds catalyze 14-hydroxylation in triptolide biosynthesis and precursor production in Saccharomyces cerevisiae

    Triptolide is a valuable multipotent antitumor diterpenoid in Tripterygium wilfordii , and its C-14 hydroxyl group is often selected for modification...

    Yifeng Zhang, Jie Gao, ... Luqi Huang in Nature Communications
    Article Open access 16 February 2023
  11. Transcriptional expression of CXCL10 and STAT1 in lupus nephritis and the intervention effect of triptolide

    Objective

    This study screened out the key genes associated with the occurrence and development of lupus nephritis (LN) using bioinformatics methods,...

    Dongliang Shi, Yan Li, ... Yinghong Yang in Clinical Rheumatology
    Article Open access 14 November 2022
  12. Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways

    Dysregulation of MDM2, a p53 negative regulator, frequently occurs in acute myeloid leukemia (AML) and is associated with unfavorable prognoses,...

    Qinwei Chen, Suqi Deng, ... Bing Xu in Experimental Hematology & Oncology
    Article Open access 16 April 2022
  13. Novel pH-sensitive triptolide-loaded micelles: a potential approach to increase anti-tumor activity of the diterpenoid epoxide

    Tripterygium wilfordii Hook F, a traditional medicine in China has bioactive but toxic triptolide (TP, a diterpenoid triepoxide) as its main active...

    Zhimeng Lu, Kun Yan, ... Hao Zhang in Journal of Nanoparticle Research
    Article Open access 01 April 2024
  14. Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity

    With the increasing epidemiology of autoimmune disease worldwide, there is an urgent need for effective drugs with low cost in clinical treatment....

    Yaxin Cheng, Yonghua Zhao, Ying Zheng in Chinese Medicine
    Article Open access 07 November 2021
  15. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine

    As a natural product with various biological activities, triptolide (TP) has been reported in anti-inflammatory, anti-tumor and anti-autoimmune...

    Rui Sun, **gyue Dai, ... Longguang Tang in Journal of Nanobiotechnology
    Article Open access 20 April 2022
  16. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma

    Immunotherapy has good potential to eradicate tumors in the long term. However, due to the low immunogenicity of tumor cells, current cancer...

    Shengmei Wang, Qiuyan Guo, ... **nhua **a in Journal of Nanobiotechnology
    Article Open access 19 October 2023
  17. Network pharmacology of triptolide in cancer cells: implications for transcription factor binding

    Background Triptolide is an active natural product, which inhibits cell proliferation, induces cell apoptosis, suppresses tumor metastasis and...

    Ean-Jeong Seo, Mona Dawood, ... Thomas Efferth in Investigational New Drugs
    Article Open access 02 July 2021
  18. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease

    Diabetes-induced chronic kidney diseases are widespread and decrease the quality of life for millions of affected individuals in China. To date, no...

    Lingyan Ren, Renrui Wan, ... **aoyi Wang in Applied Biochemistry and Biotechnology
    Article 01 October 2021
  19. Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice

    White matter injury is the major pathological alteration of subcortical ischemic vascular dementia (SIVD) caused by chronic cerebral hypoperfusion....

    Yu-shan Wan, Yi You, ... Lei Jiang in Acta Pharmacologica Sinica
    Article 06 April 2021
  20. Triptolide with hepatotoxicity and nephrotoxicity used in local delivery treatment of myocardial infarction by thermosensitive hydrogel

    Myocardial infarction (MI) resulting from coronary artery occlusion is the leading global cause of cardiovascular disability and mortality....

    Kun Wang, Ke Zhu, ... Jun Zhao in Journal of Nanobiotechnology
    Article Open access 17 July 2023
Did you find what you were looking for? Share feedback.